Skip to Content

GG 705 (Ranitidine Hydrochloride 150 mg)

Pill with imprint GG 705 is Pink, Round and has been identified as Ranitidine Hydrochloride 150 mg. It is supplied by Sandoz Pharmaceuticals Inc..

Ranitidine is used in the treatment of duodenal ulcer; erosive esophagitis; duodenal ulcer prophylaxis; gerd; cutaneous mastocytosis and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GG 705

Ranitidine hydrochloride 150 mg GG 705
Ranitidine hydrochloride 150 mg GG 705 Front
Ranitidine hydrochloride 150 mg GG 705 Back
Ranitidine hydrochloride 150 mg GG 705

Ranitidine Hydrochloride

GG 705
150 mg
8.00 mm
Rx and/or OTC
Drug Class
H2 antagonists
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Sandoz Pharmaceuticals Inc.
Inactive Ingredients
D&C Red No. 30, hydroxypropyl cellulose (type h), hypromellose 2910 (3 mPa.s), magnesium stearate, microcrystalline cellulose, peppermint, sodium starch glycolate type A potato, titanium dioxide, triethyl citrate

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00781-1883 Sandoz Inc.
51079-0879 UDL Laboratories Inc.
66267-0188 Nucare Pharmaceuticals Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.